Reticulin fibrosis in disease progression and overall survival of chronic myelomonocytic leukemia: An independent prognostic factor?

被引：0
|
作者：
Peker, D. [1 ]
Liu, J. [2 ]
Padron, E. [2 ]
Lancet, J. [2 ]
List, A. [2 ]
Komrokji, R. [2 ]
Zhang, L. [3 ]
机构：
[1] Univ Alabama Birmingham, Hematol Pathol, Birmingham, AL USA
[2] Univ S Florida, H Lee Moffitt Canc Ctr, Malignant Hematol, Tampa, FL 33682 USA
[3] Univ S Florida, H Lee Moffitt Canc Ctr, Hematopathol, Tampa, FL 33682 USA
来源：
LEUKEMIA RESEARCH | 2013年 / 37卷
关键词：
D O I：
10.1016/S0145-2126(13)70178-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-130
引用
下载
收藏
页码：S82 / S82
页数：1
相关论文
共 50 条
  • [1] Reticulin Fibrosis in Disease Progression and Overall Survival of Chronic Myelomonocytic Leukemia: An Independent Prognostic Factor?
    Peker, Deniz
    Liu, Jijun
    Zhang, Ling
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2012, 138 : A048 - A048
  • [2] Progranulin Is a Novel Independent Predictor of Disease Progression and Overall Survival in Chronic Lymphocytic Leukemia
    Goebel, Maria
    Eisele, Lewin
    Moellmann, Michael
    Huettmann, Andreas
    Johansson, Patricia
    Scholtysik, Rene
    Bergmann, Manuela
    Busch, Raymonde
    Doehner, Hartmut
    Hallek, Michael
    Seiler, Till
    Stilgenbauer, Stephan
    Klein-Hitpass, Ludger
    Duehrsen, Ulrich
    Duerig, Jan
    PLOS ONE, 2013, 8 (08):
  • [3] PROGNOSTIC FACTORS AND SURVIVAL IN CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)
    STARK, AN
    THOROGOOD, J
    HEAD, C
    ROBERTS, BE
    SCOTT, CS
    BRITISH JOURNAL OF CANCER, 1987, 56 (01) : 59 - 63
  • [4] Comorbidities Are Major Drivers of Overall Survival of Chronic Myelomonocytic Leukemia
    Broadbent, Tyson
    Tantravahi, Srinivas K.
    Ravulapati, Sowmya
    Ward, Morgan
    Asay, Alexandra
    Peddinti, Ananth
    Kunz, Isaac
    Shami, Paul J.
    Kovacsovics, Tibor
    Courdy, Samir
    Boucher, Ken
    Deininger, Michael W.
    BLOOD, 2018, 132
  • [5] Evaluation of prognostic factors for overall survival in patients with chronic myelomonocytic leukemia by different scoring systems: which is the best?
    Breccia, Massimo
    Finsinger, Paola
    Loglisci, Giuseppina
    Colafigli, Gioia
    Serrao, Alessandra
    Salaroli, Adriano
    Petrucci, Luigi
    Alimena, Giuliana
    LEUKEMIA & LYMPHOMA, 2012, 53 (10) : 2073 - 2074
  • [6] LEUKEMIC PNEUMONITIS AS A POOR PROGNOSTIC FACTOR IN CHRONIC MYELOMONOCYTIC LEUKEMIA
    YAMAUCHI, K
    OMATA, T
    RESPIRATION, 1992, 59 (02) : 119 - 121
  • [7] Soluble MICA as an independent prognostic factor for the overall survival and progression-free survival of multiple myeloma patients
    Rebmann, Vera
    Schuett, Philipp
    Brandhorst, Dieter
    Opalka, Bertram
    Moritz, Thomas
    Nowrousian, Mohammad Reza
    Grosse-Wilde, Hans
    CLINICAL IMMUNOLOGY, 2007, 123 (01) : 114 - 120
  • [8] Hemophagocytosis arising during disease progression of chronic myelomonocytic leukemia
    O'Brien, Odharnaith
    Sibai, Hassan
    Chang, Hong
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2022, 44 (01) : 25 - 26
  • [9] Effect of obesity on overall survival in patients diagnosed with chronic myelomonocytic leukemia (CMML)
    Alfakara, Dima
    Swedeh, Amer
    Kaufman, Gregory
    Patnaik, Mrinal M.
    Hashmi, Sharukh
    Hogan, William J.
    Elliott, Michelle A.
    Wolanskyj, Alexandra P.
    Liu, Shujun
    Litzow, Mark Robert
    Al-Kali, Aref
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [10] RAS Mutation Is a Poor Prognostic Factor in Patients with Chronic Myelomonocytic Leukemia
    Zhang, L.
    Aladily, T. N.
    Chakhachiro, Z.
    Yao, H.
    Su, X.
    Routbort, M.
    Wang, S. A.
    Luthra, R.
    Miranda, R.
    Medeiros, L. J.
    Bueso-Ramos, C.
    Khoury, J. D.
    LABORATORY INVESTIGATION, 2013, 93 : 369A - 369A
12345